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Background
cGMP as a second messenger regulates cardiac contrac-
tility and might protect the heart from hypertrophy and
failure by acting in distinct subcellular microdomains.
However, direct visualization of cGMP in subcellular
microdomains of adult cardiomyocytes has been challen-
ging. Little is known also about changes in cardiomyo-
cyte cGMP signalling at an early stage of the disease.
Methods
We used a highly sensitive cytosolic and membrane-
targeted Förster resonance energy transfer (FRET)-
based biosensors for cGMP and cAMP for real time mea-
surements in freshly isolated sensor-trasngenic adult ven-
tricular cardiomyocytes. Combined with single cell
contractility measurements, biochemical techniques and
whole-heart recording, the effect of atrial natriuretic pep-
tide (ANP) on cardiomyocyte cGMP/cAMP and contracti-
lity in healthy and hypertrophied hearts (after transverse
aortic constriction).
Results
Contractility measurements in hypertrophied hearts have
unravelled ANP-induced augmentation of catecholamine
stimulated increase in force and frequency of contraction
which was present only in diseased hearts at the state of
early compensated cardiac hypertrophy. Interestingly,
this effect was not due to changes in cGMP content,
membrane receptor densities or whole-cells phospho-
diesterase (PDE) activity. Instead, physical redistribution
of the cGMP-stimulated PDE2 and cGMP-inhibited
PDE3 between distinct membrane domains led to a
change of cAMP compartmentation towards an ANP/
cGMP/PDE3-dependent increase of local cAMP levels in
a microdomain regulating cardiac contractility [1]. FRET-
based cGMP measurements revealed relatively small
increase of cGMP upon ANP stimulation [2], stringent
compartmentation of ANP/cGMP signals to T-tubular
membranes and apparent absence of receptor desensiti-
zation in early cardiac hypertrophy [1].
Conclusion
ANP/cGMP signalling can play distinct roles in cardiac
disease, including a previously unrecognized contractility
augmentation in early hypertrophy which might support
heart function upon pressure overload. This can be
achieved by PDE2/3 redistribution-dependent changes in
cGMP/cAMP compartmentation.
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